Literature DB >> 21557039

CCN3-mediated promotion of sulfated proteoglycan synthesis in rat chondrocytes from developing joint heads.

Danilo Janune1, Satoshi Kubota, Noureddine Lazar, Bernard Perbal, Seiji Iida, Masaharu Takigawa.   

Abstract

Chondrocytes forming articular cartilage are embedded in a vast amount of extracellular matrix having physical stiffness and elasticity, properties that support the mechanical load from bones and enable the flexible movement of synovial joints. Unlike chondrocytes that conduct the growth of long bones by forming the growth plate, articular chondrocytes show suppressed cell proliferation, unless these cells are exposed to pathological conditions such as mechanical overload. In the present study, we found that one of the members of the CCN family, CCN3, was significantly expressed in chondrocytes isolated from the epiphyseal head in developing rat synovial joints. Evaluation of the effect of recombinant CCN3 on those chondrocytes revealed that CCN3 promoted proteoglycan synthesis, whereas this factor repressed the proliferation of the same cells. These results suggest a critical role for CCN3 in the regulation of the biological properties of articular chondrocytes.

Entities:  

Year:  2011        PMID: 21557039      PMCID: PMC3145868          DOI: 10.1007/s12079-011-0135-1

Source DB:  PubMed          Journal:  J Cell Commun Signal        ISSN: 1873-9601            Impact factor:   5.782


  21 in total

1.  Antiproliferative activity of CCN3: involvement of the C-terminal module and post-translational regulation.

Authors:  A M Bleau; N Planque; N Lazar; D Zambelli; A Ori; T Quan; G Fisher; K Scotlandi; B Perbal
Journal:  J Cell Biochem       Date:  2007-08-15       Impact factor: 4.429

2.  Association of the metastatic phenotype with CCN family members among breast and oral cancer cells.

Authors:  Toshihiro Ohgawara; Satoshi Kubota; Harumi Kawaki; Naito Kurio; Tarek Abd El Kader; Mitsuhiro Hoshijima; Danilo Janune; Tsuyoshi Shimo; Bernard Perbal; Akira Sasaki; Masaharu Takigawa
Journal:  J Cell Commun Signal       Date:  2011-04-18       Impact factor: 5.782

3.  CCN3 inhibits neointimal hyperplasia through modulation of smooth muscle cell growth and migration.

Authors:  Tatsushi Shimoyama; Shûichi Hiraoka; Minoru Takemoto; Masaya Koshizaka; Hirotake Tokuyama; Takahiko Tokuyama; Aki Watanabe; Masaki Fujimoto; Harukiyo Kawamura; Seiya Sato; Yuya Tsurutani; Yasushi Saito; Bernard Perbal; Haruhiko Koseki; Koutaro Yokote
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-02-05       Impact factor: 8.311

4.  Expression and physiological role of CCN4/Wnt-induced secreted protein 1 mRNA splicing variants in chondrocytes.

Authors:  Takeshi Yanagita; Satoshi Kubota; Harumi Kawaki; Kazumi Kawata; Seiji Kondo; Teruko Takano-Yamamoto; Shinji Tanaka; Masaharu Takigawa
Journal:  FEBS J       Date:  2007-04       Impact factor: 5.542

Review 5.  CCN proteins: multifunctional signalling regulators.

Authors:  Bernard Perbal
Journal:  Lancet       Date:  2004-01-03       Impact factor: 79.321

6.  CCN3 (NOV) is a novel angiogenic regulator of the CCN protein family.

Authors:  Cristiane G Lin; Shr-Jeng Leu; Ningyu Chen; Christopher M Tebeau; Shao-Xia Lin; Cho-Yau Yeung; Lester F Lau
Journal:  J Biol Chem       Date:  2003-04-13       Impact factor: 5.157

7.  CTGF/Hcs24, a hypertrophic chondrocyte-specific gene product, stimulates proliferation and differentiation, but not hypertrophy of cultured articular chondrocytes.

Authors:  Takashi Nishida; Satoshi Kubota; Tohru Nakanishi; Takuo Kuboki; Gen Yosimichi; Seiji Kondo; Masaharu Takigawa
Journal:  J Cell Physiol       Date:  2002-07       Impact factor: 6.384

Review 8.  Functions and mechanisms of action of CCN matricellular proteins.

Authors:  Chih-Chiun Chen; Lester F Lau
Journal:  Int J Biochem Cell Biol       Date:  2008-08-15       Impact factor: 5.085

9.  Downregulation of CCN3 expression as a potential mechanism for melanoma progression.

Authors:  M Fukunaga-Kalabis; G Martinez; S M Telson; Z-J Liu; K Balint; I Juhasz; D E Elder; B Perbal; M Herlyn
Journal:  Oncogene       Date:  2007-10-29       Impact factor: 8.756

10.  Abnormal skeletal and cardiac development, cardiomyopathy, muscle atrophy and cataracts in mice with a targeted disruption of the Nov (Ccn3) gene.

Authors:  Emma Heath; Dalal Tahri; Elisabetta Andermarcher; Paul Schofield; Stewart Fleming; Catherine A Boulter
Journal:  BMC Dev Biol       Date:  2008-02-20       Impact factor: 1.978

View more
  6 in total

1.  CCN3: the-pain-killer inside me.

Authors:  Bernard Perbal
Journal:  J Cell Commun Signal       Date:  2012-03-30       Impact factor: 5.782

2.  Metabolic regulation of the CCN family genes by glycolysis in chondrocytes.

Authors:  Sho Akashi; Takashi Nishida; Abdellatif El-Seoudi; Masaharu Takigawa; Seiji Iida; Satoshi Kubota
Journal:  J Cell Commun Signal       Date:  2017-11-11       Impact factor: 5.782

3.  Targeted mutation of NOV/CCN3 in mice disrupts joint homeostasis and causes osteoarthritis-like disease.

Authors:  K A Roddy; C A Boulter
Journal:  Osteoarthritis Cartilage       Date:  2014-12-22       Impact factor: 6.576

Review 4.  The Emerging Roles of CCN3 Protein in Immune-Related Diseases.

Authors:  Linan Peng; Yingying Wei; Yijia Shao; Yi Li; Na Liu; Lihua Duan
Journal:  Mediators Inflamm       Date:  2021-05-18       Impact factor: 4.711

5.  A friend in knee: CCN3 may inhibit osteoarthritis progression.

Authors:  Alex Peidl
Journal:  J Cell Commun Signal       Date:  2018-01-13       Impact factor: 5.782

Review 6.  CCN proteins in the musculoskeletal system: current understanding and challenges in physiology and pathology.

Authors:  Veronica Giusti; Katia Scotlandi
Journal:  J Cell Commun Signal       Date:  2021-07-06       Impact factor: 5.782

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.